Metabolomic Technologies fetches Series A
Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
22 October 2019•1 min read
Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
